113 related articles for article (PubMed ID: 36112052)
1. Contrast Enhancement Patterns in Pediatric Glioblastomas.
Pokhylevych H; Khose S; Gule-Monroe MK; Chen MM; Fuller G; Gruschkus SK; Sadighi Z; Zaky W; Sandberg DI; McGovern SL; Johnson JM
J Comput Assist Tomogr; 2023 Jan-Feb 01; 47(1):115-120. PubMed ID: 36112052
[TBL] [Abstract][Full Text] [Related]
2. Morphologic Features on MR Imaging Classify Multifocal Glioblastomas in Different Prognostic Groups.
Pérez-Beteta J; Molina-García D; Villena M; Rodríguez MJ; Velásquez C; Martino J; Meléndez-Asensio B; Rodríguez de Lope Á; Morcillo R; Sepúlveda JM; Hernández-Laín A; Ramos A; Barcia JA; Lara PC; Albillo D; Revert A; Arana E; Pérez-García VM
AJNR Am J Neuroradiol; 2019 Apr; 40(4):634-640. PubMed ID: 30923085
[TBL] [Abstract][Full Text] [Related]
3. Dynamic Contrast-Enhanced MR Imaging of Nonenhancing T2 High-Signal-Intensity Lesions in Baseline and Posttreatment Glioblastoma: Temporal Change and Prognostic Value.
Hwang I; Choi SH; Park CK; Kim TM; Park SH; Won JK; Kim IH; Lee ST; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH
AJNR Am J Neuroradiol; 2020 Jan; 41(1):49-56. PubMed ID: 31806595
[TBL] [Abstract][Full Text] [Related]
4. Ventricle contact is associated with lower survival and increased peritumoral perfusion in glioblastoma.
van Dijken BRJ; Jan van Laar P; Li C; Yan JL; Boonzaier NR; Price SJ; ; van der Hoorn A
J Neurosurg; 2018 Oct; 131(3):717-723. PubMed ID: 30485234
[TBL] [Abstract][Full Text] [Related]
5. The clinical characteristics and prognostic factors of multiple lesions in glioblastomas.
Tunthanathip T; Sangkhathat S; Tanvejsilp P; Kanjanapradit K
Clin Neurol Neurosurg; 2020 Aug; 195():105891. PubMed ID: 32480195
[TBL] [Abstract][Full Text] [Related]
6. Pediatric glioblastoma: clinico-radiological profile and factors affecting the outcome.
Das KK; Mehrotra A; Nair AP; Kumar S; Srivastava AK; Sahu RN; Kumar R
Childs Nerv Syst; 2012 Dec; 28(12):2055-62. PubMed ID: 22903238
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of Histogram-Profile Analysis in Ring-Enhancing Intracranial Lesions.
Kolakshyapati M; Hashizume A; Ochi K; Ueno H; Kaichi Y; Takayasu T; Takano M; Karlowee V; Akiyama Y; Awai K; Maruyama H; Sugiyama K; Kurisu K; Yamasaki F
World Neurosurg; 2019 Nov; 131():e226-e236. PubMed ID: 31349079
[TBL] [Abstract][Full Text] [Related]
8. Multiparametric MR Imaging of Diffusion and Perfusion in Contrast-enhancing and Nonenhancing Components in Patients with Glioblastoma.
Boonzaier NR; Larkin TJ; Matys T; van der Hoorn A; Yan JL; Price SJ
Radiology; 2017 Jul; 284(1):180-190. PubMed ID: 28240563
[TBL] [Abstract][Full Text] [Related]
9. Early post-operative magnetic resonance imaging in glioblastoma: correlation among radiological findings and overall survival in 60 patients.
Majós C; Cos M; Castañer S; Gil M; Plans G; Lucas A; Bruna J; Aguilera C
Eur Radiol; 2016 Apr; 26(4):1048-55. PubMed ID: 26188660
[TBL] [Abstract][Full Text] [Related]
10. Histogram analysis of amide proton transfer-weighted imaging: comparison of glioblastoma and solitary brain metastasis in enhancing tumors and peritumoral regions.
Kamimura K; Nakajo M; Yoneyama T; Fukukura Y; Hirano H; Goto Y; Sasaki M; Akamine Y; Keupp J; Yoshiura T
Eur Radiol; 2019 Aug; 29(8):4133-4140. PubMed ID: 30488111
[TBL] [Abstract][Full Text] [Related]
11. Differentiating Between Primary Central Nervous System Lymphomas and Glioblastomas: Combined Use of Perfusion-Weighted and Diffusion-Weighted Magnetic Resonance Imaging.
Makino K; Hirai T; Nakamura H; Kuroda JI; Shinojima N; Uetani H; Kitajima M; Yano S
World Neurosurg; 2018 Apr; 112():e1-e6. PubMed ID: 29104150
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Predictions for Patients with Glioblastoma after Standard Treatment: Application of Contrast Leakage Information from DSC-MRI within Nonenhancing FLAIR High-Signal-Intensity Lesions.
Kim SH; Cho KH; Choi SH; Kim TM; Park CK; Park SH; Won JK; Kim IH; Lee ST
AJNR Am J Neuroradiol; 2019 Dec; 40(12):2052-2058. PubMed ID: 31727756
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of contrast-enhancing anaplastic astrocytomas in adults.
Chaichana KL; Kosztowski T; Niranjan A; Olivi A; Weingart JD; Laterra J; Brem H; Quiñones-Hinojosa A
J Neurosurg; 2010 Aug; 113(2):286-92. PubMed ID: 20302391
[TBL] [Abstract][Full Text] [Related]
14. Clinical Features and Prognostic Factors of Pediatric Glioblastoma: Report of 38 Cases.
Jiao Y; Wang M; Liu X; Wang J; Wang Z; Luo W; Yu Y; Sun H
World Neurosurg; 2021 Sep; 153():e105-e111. PubMed ID: 34129988
[TBL] [Abstract][Full Text] [Related]
15. Pathological and clinical features of cystic and noncystic glioblastomas.
Utsuki S; Oka H; Suzuki S; Shimizu S; Tanizaki Y; Kondo K; Tanaka S; Kawano N; Fujii K
Brain Tumor Pathol; 2006 Apr; 23(1):29-34. PubMed ID: 18095116
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of brain infection from necrotic glioblastoma using combined analysis of diffusion and perfusion MRI.
Chawla S; Wang S; Mohan S; Nasrallah M; Verma G; Brem S; O'Rourke DM; Wolf RL; Poptani H; Nabavizadeh SA
J Magn Reson Imaging; 2019 Jan; 49(1):184-194. PubMed ID: 29676844
[TBL] [Abstract][Full Text] [Related]
17. Early-Stage Glioblastomas: MR Imaging-Based Classification and Imaging Evidence of Progressive Growth.
Toh CH; Castillo M
AJNR Am J Neuroradiol; 2017 Feb; 38(2):288-293. PubMed ID: 27856439
[TBL] [Abstract][Full Text] [Related]
18. Endoscope-assisted fluorescence-guided resection allowing supratotal removal in glioblastoma surgery.
Bettag C; Schregel K; Langer P; Thomas C; Behme D; Stadelmann C; Rohde V; Mielke D
Neurosurg Focus; 2021 Jan; 50(1):E3. PubMed ID: 33386004
[TBL] [Abstract][Full Text] [Related]
19. Utility of dynamic contrast-enhanced magnetic resonance imaging for differentiating glioblastoma, primary central nervous system lymphoma and brain metastatic tumor.
Lu S; Gao Q; Yu J; Li Y; Cao P; Shi H; Hong X
Eur J Radiol; 2016 Oct; 85(10):1722-1727. PubMed ID: 27666608
[TBL] [Abstract][Full Text] [Related]
20. Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator.
Kolakshyapati M; Adhikari RB; Karlowee V; Takayasu T; Nosaka R; Amatya VJ; Takeshima Y; Akiyama Y; Sugiyama K; Kurisu K; Yamasaki F
J Neurosurg; 2018 Mar; 128(3):667-678. PubMed ID: 28362236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
